Group 1 - Strive Inc. announced an all-stock acquisition of Semler Scientific [1] - Strive purchased 5,816 bitcoins at an average price of $116,047 each, totaling approximately $675 million, increasing its bitcoin holdings to 5,886 [1] - Post-merger, the combined companies will hold over 10,900 bitcoins and plan to explore further monetization or expansion of Semler's research diagnostics business [1]

Core Points - The Gross Law Firm has issued a notice to shareholders of Semler Scientific, Inc. regarding a class action lawsuit for alleged misleading statements and failure to disclose a material investigation by the U.S. Department of Justice [1][2] - The class period for the allegations spans from March 10, 2021, to April 15, 2025, with a deadline for shareholders to register for the class action by October 28, 2025 [2] - The firm emphasizes its commitment to protecting investors' rights and ensuring companies adhere to responsible business practices [3] Summary by Sections Allegations - The complaint alleges that Semler Scientific did not disclose a material investigation by the U.S. Department of Justice related to violations of the False Claims Act, while discussing potential violations in hypothetical terms [1] - As a result, the defendants' public statements were materially false and/or misleading throughout the relevant period [1] Class Action Details - Shareholders who purchased shares of SMLR during the specified class period are encouraged to contact the Gross Law Firm for possible lead plaintiff appointment [1] - Registration for the class action is free, and participants will receive updates through portfolio monitoring software [2] Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors from deceit, fraud, and illegal business practices [3] - The firm aims to recover losses incurred by investors due to false or misleading statements that led to artificial inflation of stock prices [3]

Mergers and Acquisitions - Strive (ASST) entered into a definitive agreement to acquire Semler Scientific (SMLR) in an all-stock transaction [1] - Semler Scientific's Eric Semler to join Strive board post close [1] Bitcoin Holdings - Strive announced the purchase of 5,816 Bitcoin [1] - The combined company will hold more than 10,900 Bitcoin [1] Business Strategy - Post-merger intention to monetize or distribute Semler Scientific's historically profitable diagnostics business [1]

Core Viewpoint - Strive, Inc. has entered into a definitive agreement to acquire Semler Scientific, Inc. in an all-stock transaction, enhancing its position as a leading Bitcoin treasury company and expanding its business into medical diagnostics [1][2]. Company Overview - Strive, Inc. is the first publicly traded asset management Bitcoin treasury company, currently holding 5,886 Bitcoin and managing over $2 billion in assets since launching its first ETF in August 2022 [4]. - Semler Scientific, Inc. is a leader in medical devices and software aimed at combating chronic diseases and is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset [6][7]. Transaction Details - The acquisition represents an approximately 210% premium, equivalent to about $90.52 per share, based on the trading prices as of September 19, 2025 [6]. - Each common share of Semler Scientific will be exchanged for 21.05 Class A common shares of Strive [6]. - The combined company will own over 10,900 Bitcoin prior to any additional Bitcoin raised from future financings [6]. Strategic Goals - The merger aims to create significant value for stockholders by delivering a substantial premium and expanding into a robust preventative care and wellness platform focused on early detection of chronic diseases [2][6]. - Strive's management intends to operate with a "preferred equity only" leverage model to avoid debt maturity risks associated with traditional leveraged Bitcoin strategies [6]. Legal and Financial Advisory - Davis Polk & Wardwell LLP is serving as legal counsel to Strive, while Goodwin Procter LLP is legal counsel to Semler Scientific [3]. - Cantor Fitzgerald, L.P. is the financial advisor to Strive, and LionTree Advisors LLC is the financial advisor to Semler Scientific [3].

Group 1 - The law firm Faruqi & Faruqi, LLP is investigating potential claims against Semler Scientific, Inc. and has set a deadline of October 28, 2025, for investors to seek the role of lead plaintiff in a federal securities class action [2][4] - The complaint alleges that Semler Scientific and its executives violated federal securities laws by making false or misleading statements and failing to disclose a material investigation by the U.S. Department of Justice regarding violations of the False Claims Act [4][5] - Following the disclosure of initial settlement discussions with the DOJ, Semler Scientific's stock fell over 9% on the next trading day, indicating a significant market reaction to the news [5] Group 2 - Investors who suffered losses exceeding $75,000 in Semler Scientific between March 10, 2021, and April 15, 2025, are encouraged to contact the law firm to discuss their legal rights [1][7] - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995, highlighting its experience and capability in handling securities litigation [3]

Core Viewpoint - A class action securities lawsuit has been filed against Semler Scientific, Inc. for alleged securities fraud affecting investors between March 10, 2021, and April 15, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Semler Scientific failed to disclose a significant investigation by the U.S. Department of Justice regarding violations of the False Claims Act, while discussing potential violations in hypothetical terms [2]. - As a result of these actions, the public statements made by the defendants were materially false and misleading throughout the relevant period [2]. Group 2: Next Steps for Investors - Investors who experienced losses in Semler Scientific during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be eligible for compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [4].

Accessibility StatementSkip Navigation NEW YORK, Sept. 19, 2025 /PRNewswire/ -- Levi &Â Korsinsky, LLP notifies investors in Semler Scientific, Inc. ("Semler Scientific, Inc." or the "Company") (NASDAQ: SMLR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Semler Scientific, Inc. investors who were adversely affected by alleged securities fraud between March 10, 2021 and April 15, 2025. Follow the link below to get more information and be contacted by ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Semler Scientific, Inc. due to allegations of violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by October 28, 2025 [2][4]. Group 1: Legal Investigation - The investigation focuses on claims that Semler Scientific and its executives made false or misleading statements and failed to disclose a material investigation by the U.S. Department of Justice regarding violations of the False Claims Act [4]. - The company disclosed in its 2024 annual report that it began initial settlement discussions with the DOJ on February 11, 2025, but ceased those discussions the same day, indicating a risk of a civil lawsuit [5]. Group 2: Financial Impact - Following the disclosure of the DOJ investigation and the cessation of settlement discussions, Semler Scientific's stock price fell over 9% on the next trading day [5]. - Investors who suffered losses exceeding $75,000 between March 10, 2021, and April 15, 2025, are encouraged to contact the law firm to discuss their legal options [1].

Core Viewpoint - Semler Scientific, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding a Department of Justice investigation into violations of the False Claims Act during the class period from March 10, 2021, to April 15, 2025 [3][4]. Group 1 - The class action lawsuit is based on allegations that Semler Scientific failed to disclose a material investigation by the United States Department of Justice, which is related to potential violations of the False Claims Act [3]. - The lawsuit claims that the defendants' public statements were materially false and misleading throughout the relevant time period [3]. - Shareholders who purchased shares of Semler Scientific during the specified class period are encouraged to register for the class action and may seek lead plaintiff status by the deadline of October 28, 2025 [4]. Group 2 - The Gross Law Firm, which is handling the case, is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered losses due to deceit and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that led to artificial inflation of stock prices [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Semler Scientific, Inc. regarding violations of federal securities laws, particularly related to undisclosed investigations by the U.S. Department of Justice [4][6]. Group 1: Legal Investigation and Claims - The firm is encouraging investors who suffered losses in Semler Scientific to contact them to discuss their legal options [1][9]. - A federal securities class action has been filed against Semler Scientific, with a deadline of October 28, 2025, for investors to seek the role of lead plaintiff [4][8]. - The complaint alleges that Semler Scientific and its executives made false or misleading statements and failed to disclose a material investigation by the DOJ into violations of the False Claims Act [6][7]. Group 2: Company Financial Impact - Following the disclosure of initial settlement discussions with the DOJ, Semler Scientific's stock fell over 9% on the next trading day [7]. - The annual report filed with the SEC indicated that the company does not believe the amount of loss from potential DOJ actions can be reasonably estimated [7]. Group 3: Firm Background - Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its founding in 1995 and has offices in multiple states [5].